A prospective study of appropriate follow-up interval for high-risk group of branch duct type intraductal papillary mucinous neoplasms of the pancreas

A prospective study of appropriate follow-up interval for high-risk group of branch duct type intraductal papillary mucinous neoplasms of the pancreas - A prospective study of appropriate follow-up interval for high-risk group of branch duct type IPMN

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000016989

Enrollment

155

Registered

2015-03-31

Start date

2013-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Branch duct type intraductal papillary mucious neoplasms of the pancreas

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Branch duct type IPMN greater than 30 mm in size

Exclusion criteria

Exclusion criteria: 1) A concurrence of pancreatic malignancies at the time of diagnosis of IPMN. 2) The contraindication or rejection for the imaging examinations by EUS or MRCP. 3) The patients from whom the informed consent cannot be obtained. 4) The patients who are judged inappropriate for the participation for this study by the attending doctor.

Design outcomes

Primary

Measure	Time frame
The Stages of invasive cancers derived from IPMN	—

Secondary

Measure	Time frame
1)Prognosis 2)Factors associated with an onset of invasive cancers derived from IPMN 3)Progression of IPMN	—

Countries

Japan

Contacts

Public ContactShinsuke Koshita

Sendai City Medical Center Department of Gastroenterology

skoshita@openhp.or.jp+81-22-252-1111

Outcome results